MAIA Biotechnology, Inc. (MAIA)
1.33
-0.05
(-3.62%)
USD |
NYAM |
Aug 28, 16:00
1.325
0.00 (0.00%)
After-Hours: 20:00
MAIA Biotechnology Free Cash Flow : -22.57M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -22.57M |
| March 31, 2026 | -19.95M |
| December 31, 2025 | -18.84M |
| September 30, 2025 | -15.73M |
| June 30, 2025 | -15.77M |
| March 31, 2025 | -16.32M |
| December 31, 2024 | -15.70M |
| September 30, 2024 | -15.79M |
| June 30, 2024 | -15.42M |
| March 31, 2024 | -13.30M |
| Date | Value |
|---|---|
| December 31, 2023 | -13.07M |
| September 30, 2023 | -11.59M |
| June 30, 2023 | -12.75M |
| March 31, 2023 | -12.47M |
| December 31, 2022 | -11.66M |
| September 30, 2022 | -10.75M |
| June 30, 2022 | -7.746M |
| March 31, 2022 | -6.415M |
| December 31, 2021 | -4.123M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Regeneron Pharmaceuticals, Inc. | 3.575B |
| TG Therapeutics, Inc. | 17.38M |
| ACADIA Pharmaceuticals, Inc. | 145.62M |
| Alnylam Pharmaceuticals, Inc. | 793.94M |
| Anika Therapeutics, Inc. | 0.562M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -6.750M |
| Cash from Financing (Quarterly) | -0.065M |
| Free Cash Flow Per Share (Quarterly) | -0.111 |
| Free Cash Flow to Equity (Quarterly) | -6.750M |
| Free Cash Flow to Firm (Quarterly) | -6.750M |
| Free Cash Flow Yield | -38.17% |